UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

GLUT4 and UBC9 protein expression is reduced in muscle from type 2 diabetic patients with severe insulin resistance

PloS one, 2011-11, Vol.6 (11), p.e27854-e27854

2011

Volltextzugriff (PDF)

Reduced mRNA and Protein Expression of Perilipin A and G0/G1 Switch Gene 2 (G0S2) in Human Adipose Tissue in Poorly Controlled Type 2 Diabetes

The journal of clinical endocrinology and metabolism, 2012-07, Vol.97 (7), p.E1348-E1352

2012

Volltextzugriff (PDF)

Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial

Diabetic medicine, 2013-11, Vol.30 (11), p.1298-1304

2013

Volltextzugriff (PDF)

Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency – a double-blind, randomized, placebo-controlled trial

Metabolism, clinical and experimental, 2014-09, Vol.63 (9), p.1115-1124

2014

Volltextzugriff (PDF)

The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus

Metabolism, clinical and experimental, 1999-07, Vol.48 (7), p.935-941

1999

Volltextzugriff (PDF)

Effects of 12weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency – a double-blind, randomized, placebo-controlled trial

Metabolism, clinical and experimental, 2014-09, Vol.63 (9), p.1115-1124

2014

Volltextzugriff (PDF)

Amylin receptor agonists: a novel pharmacological approach in the management of insulin-treated diabetes mellitus

Expert opinion on investigational drugs, 2001-09, Vol.10 (9), p.1641-1652

2001

Volltextzugriff (PDF)

Alcohol and glucose counterregulation during acute insulin-induced hypoglycemia in type 2 diabetic subjects

Metabolism, clinical and experimental, 2001-04, Vol.50 (4), p.451-457

2001

Volltextzugriff (PDF)

Acute effects of the human amylin analog AC137 on basal and insulin-stimulated euglycemic and hypoglycemic fuel metabolism in patients with insulin-dependent diabetes mellitus

The journal of clinical endocrinology and metabolism, 1996-03, Vol.81 (3), p.1083-1089

1996

Volltextzugriff (PDF)

Metabolic effects of growth hormone in humans

Metabolism, clinical and experimental, 1995-10, Vol.44 (10), p.33-36

1995

Volltextzugriff (PDF)

GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody

Endocrinology (Philadelphia), 2014-04, Vol.155 (4), p.1280-1290

2014

Volltextzugriff (PDF)

Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis

Molecular metabolism (Germany), 2020-12, Vol.42, p.101080-101080, Article 101080

2020

Volltextzugriff (PDF)

Evaluation of commercially available glucagon receptor antibodies and glucagon receptor expression

Communications biology, 2022-11, Vol.5 (1), p.1278-1278, Article 1278

2022

Volltextzugriff (PDF)

Expression Profile of the GLP-1 Receptor in the Gastrointestinal Tract and Pancreas in Adult Female Mice

Endocrinology (Philadelphia), 2022-01, Vol.163 (1), p.1

2022

Volltextzugriff (PDF)

Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes

European journal of endocrinology, 2007-06, Vol.156 (6), p.663-671

2007

Volltextzugriff (PDF)

Meal-Stimulated Glucagon Release Is Associated with Postprandial Blood Glucose Level and Does Not Interfere with Glycemic Control in Children and Adolescents with New-Onset Type 1 Diabetes

The journal of clinical endocrinology and metabolism, 2007-08, Vol.92 (8), p.2910-2916

2007

Volltextzugriff (PDF)

Exendin-4, but not dipeptidyl peptidase IV inhibition, increases small intestinal mass in GK rats

American journal of physiology: Gastrointestinal and liver physiology, 2007-07, Vol.293 (1), p.G288-G295

2007

Volltextzugriff (PDF)

The truncated metabolite GLP-2 (3–33) interacts with the GLP-2 receptor as a partial agonist

Regulatory peptides, 2002-01, Vol.103 (1), p.9-15

2002

Volltextzugriff (PDF)

Variety in growth hormone determinations due to use of different immunoassays and to the interference of growth hormone-binding protein

Hormone research, 1999, Vol.51 Suppl 1 (Suppl. 1), p.20-26

1999

Volltextzugriff (PDF)

Exendin-4, but not dipeptidyl peptidase IV inhibition, increases small intestinal mass in GK rats

American journal of physiology: Gastrointestinal and liver physiology, 2007, Vol.56 (1)

2007

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

GLUT4 and UBC9 protein expression is reduced in muscle from type 2 diabetic patients with severe insulin resistance

Reduced mRNA and Protein Expression of Perilipin A and G0/G1 Switch Gene 2 (G0S2) in Human Adipose Tissue in Poorly Controlled Type 2 Diabetes

Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial

Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency – a double-blind, randomized, placebo-controlled trial

The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus

Effects of 12weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency – a double-blind, randomized, placebo-controlled trial

Amylin receptor agonists: a novel pharmacological approach in the management of insulin-treated diabetes mellitus

Alcohol and glucose counterregulation during acute insulin-induced hypoglycemia in type 2 diabetic subjects

Acute effects of the human amylin analog AC137 on basal and insulin-stimulated euglycemic and hypoglycemic fuel metabolism in patients with insulin-dependent diabetes mellitus

Metabolic effects of growth hormone in humans

GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody

Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis

Evaluation of commercially available glucagon receptor antibodies and glucagon receptor expression

Expression Profile of the GLP-1 Receptor in the Gastrointestinal Tract and Pancreas in Adult Female Mice

Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes

Meal-Stimulated Glucagon Release Is Associated with Postprandial Blood Glucose Level and Does Not Interfere with Glycemic Control in Children and Adolescents with New-Onset Type 1 Diabetes

Exendin-4, but not dipeptidyl peptidase IV inhibition, increases small intestinal mass in GK rats

The truncated metabolite GLP-2 (3–33) interacts with the GLP-2 receptor as a partial agonist

Variety in growth hormone determinations due to use of different immunoassays and to the interference of growth hormone-binding protein

Exendin-4, but not dipeptidyl peptidase IV inhibition, increases small intestinal mass in GK rats

Suchergebnisse filtern